Abbott Laboratories (ABT) Holding Strong: What’s pushing it?

In yesterday’s Wall Street session, Abbott Laboratories (NYSE:ABT) shares traded at $111.50, up 1.35% from the previous session. ABT stock price is now -3.21% away from the 50-day moving average and 4.91% away from the 200-day moving average. The market capitalization of the company currently stands at $193.47B. On May 30, 2023, Morgan Stanley Downgraded […]

Abbott Laboratories (ABT) – it’s time to buy. Check out key Indicators

In yesterday’s Wall Street session, Abbott Laboratories (NYSE:ABT) shares traded at $112.44, down -2.64% from the previous session. ABT stock price is now -2.49% away from the 50-day moving average and 6.06% away from the 200-day moving average. The market capitalization of the company currently stands at $195.10B. On May 30, 2023, Morgan Stanley Downgraded […]

An overview of Abbott Laboratories’s (ABT) institutional holdings

In yesterday’s Wall Street session, Abbott Laboratories (NYSE:ABT) shares traded at $107.25, up 0.53% from the previous session. 24 analysts cover Abbott Laboratories (NYSE:ABT), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $133.00 and a low of […]

Despite Abbott Laboratories [ABT]’s great opportunity, the stock is a bit overvalued

In yesterday’s Wall Street session, Abbott Laboratories (NYSE:ABT) shares traded at $104.94, up 0.57% from the previous session. 24 analysts cover Abbott Laboratories (NYSE:ABT), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $133.00 and a low of […]

The shares of Abbott Laboratories (ABT) have recorded the market capitalization of 181.05B

The stock of Abbott Laboratories (NYSE:ABT) last traded at $104.29, up 0.64% from the previous session. Data from the available sources indicates that Abbott Laboratories (NYSE:ABT) is covered by 23 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $133.00 and […]

Abbott Laboratories (NYSE:ABT): A Fundamentally Weighted Stock for Long-Term Investors

The stock of Abbott Laboratories (NYSE:ABT) last traded at $99.55, down -0.71% from the previous session. Data from the available sources indicates that Abbott Laboratories (NYSE:ABT) is covered by 24 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $133.00 and […]

Abbott Laboratories (NYSE:ABT) Risks You Should Know Before Investing

The price of Abbott Laboratories (NYSE:ABT) shares last traded on Wall Street rose 1.35% to $97.08. Based on available information, 25 analysts follow Abbott Laboratories (NYSE:ABT). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $133.00 and a low of $100.00, we […]

Abbott Laboratories [ABT] attracts people because of its fundamentals

Abbott Laboratories (NYSE:ABT) shares traded -1.20% lower at $92.85 on Wall Street last session. In accordance with the data, 26 analysts cover Abbott Laboratories (NYSE:ABT). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $133.00 and a low of $100.00, we find […]